At Bruckner, Skepticism Is A Virtue

At Bruckner,Skepticism Is A Virtue

For over 20 years, Bruckner has delivered first-in-class strategic and tactical planning to the biopharma, device, and diagnostic industries. We love working closely with founders and VCs to create transformational development strategies that endure. Our clients routinely build long-term relationships with Bruckner that become strategic partnerships.

We have frequently defined the curve with a lengthy history of understanding what’s around the corner, envisioning new possibilities, and revealing better pathways. We engage in an unrelenting process. We are innovative truth-tellers, focused intensely on increasing the value of your assets. Our clients have come to expect the unexpected — but in a good way.

Ultimately, we are motivated simply by caring about what we do. We’re passionate about the life sciences industry and the entrepreneurs who beat the odds and make the impossible happen. We’re excited to do our part helping companies achieve success and moving the needle on treating difficult diseases. We know what this means to patients, and really to all of us.


Do current best practices for constructing clinical development programs and trials truly have you covered? If you think they do, why are they resulting in an 86% failure rate, not even including post-launch commercial flops? Current methods have multiple blind spots, rely on false truisms, and ignore emergent market shifts, all resulting in a minefield of hidden risk. While this paradigm may work for large biopharma companies that can afford to have one rare success out of scores of attempts, it’s dangerous for start-ups who have to get it right.

You can count on us to always speak truth to power. The risks and opportunities you face warrant Bruckner’s candor and rigor. We believe every product deserves its own dedicated process that breaks down barriers to get to the truth of what steps you need to take to reach success.


We are obsessed with value. Delivering value to clients. Increasing the value of clients’ assets. Bringing value to the healthcare system. Valuing our clients. Value is our mantra.

A new product’s healthcare value must be mindfully created and nurtured starting early in the process and interwoven throughout all stages of development. We leverage our integrative approach to creatively mine value simultaneously from all relevant domains, including clinical, regulatory, operational, payer, and commercial. Our work is not done until we close the loop, providing methods to codify and capture the identified potential throughout the development process.

Value comes from both identifying opportunities and risks. For some clients, we have transformed their programs by opening up a new world of clinical and healthcare value possibilities. For others, we have helped them avert almost certain disasters.


We are like you: curious, independent thinkers, always looking for ways to do better. We founded our company in our first tiny office above a garage because we tired of biopharma’s acceptance of failure, recognizing the industry’s need for new ideas and solutions.

It was just natural that our strategy work would lead to the development of pioneering methods that produce superior results for our clients. With Bruckner, you can expect forward-thinking, often unexpected, actionable strategies and tactical plans from a true partner who understands and supports your vision.

Case Studies

So, here is where you would expect to find our case studies. In the spirit of innovative truth-telling, we decided to spare you the artifice of slogging through routine, blinded hyperbole.

Just call us. We are happy to discuss how we have helped our clients.

Let's Talk